A Clinical Registry to Assess Performance and Clinical Utility of the SpyGlass Direct Visualization System
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Procedural Success as Defined by: 1. Ability to Visualize Stricture & Obtain Biopsy of Lesion Adequate for Histological Examination in Suspected Malignancy Cases or 2. Ability to Visualize Stone(s) & Successfully Initiate Stone Fragmentation & Removal.
During Procedure
No
Joyce Peetermans, PhD
Study Director
Boston Scientific Corporation
United States: Institutional Review Board
E7012
NCT00751998
November 2006
October 2009
Name | Location |
---|---|
Cleveland Clinic Foundation | Cleveland, Ohio 44195 |
Mayo Clinic | Rochester, Minnesota 55905 |
Fox Chase Cancer Center | Philadelphia, Pennsylvania 19111 |
Medical University of South Carolina | Charleston, South Carolina 29425-0721 |
Beth Israel Deaconess Medical Center | Boston, Massachusetts 02215 |
University of Pittsburgh | Pittsburgh, Pennsylvania 15261 |
University of Colorado Hospital | Denver, Colorado 80262 |
California Pacific Medical Center | San Francisco, California 94115 |
Indiana University Medical Center | Indianapolis, Indiana 46202 |
Columbia University Medical Center | New York, New York 10032 |